Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reactions were nausea and vomiting.
The table below shows the most common adverse reactions that happened in 3 or
more participants during the study. There were other adverse reactions, but these
happened in fewer participants.
Most common adverse reactions during the study
MEDI0382 Placebo
(out of 21 participants) (out of 20 participants)
Nausea 33.3% (7) 20.0% (4)
Vomiting 23.8% (5) 5.0% (1)
Diarrhoea 19.0% (4) 0.0% (0)
Indigestion 14.3% (3) 5.0% (1)
Low appetite 14.3% (3) 0.0% (0)
Low blood glucose
14.3% (3) 0.0% (0)
(hypoglycaemia)
How has this study helped patients and
researchers?
This study helped researchers learn more about using MEDI0382 in participants
with T2DM and kidney problems.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with MEDI0382 are planned.
7